The chemist and druggist [electronic resource] . p. Meanwhile, Benylin Dayand Night is holding itsmarket share, say WarnerLambert. The brand will bepart of a £2m spend for thetotal Benylin range. Cold sufferers prefer totake fluid treatments at nighttime and capsules during theday, according to A AH. TheVantage own-label winter Cold remedies areworth over £49million, accordingto lead the market andSB say it has a brandawareness of 93 per cent, withgrowth of more than 13 percent a year. This Winter willsee an advertising campaignwith a £lm marketingsupport package for th


The chemist and druggist [electronic resource] . p. Meanwhile, Benylin Dayand Night is holding itsmarket share, say WarnerLambert. The brand will bepart of a £2m spend for thetotal Benylin range. Cold sufferers prefer totake fluid treatments at nighttime and capsules during theday, according to A AH. TheVantage own-label winter Cold remedies areworth over £49million, accordingto lead the market andSB say it has a brandawareness of 93 per cent, withgrowth of more than 13 percent a year. This Winter willsee an advertising campaignwith a £lm marketingsupport package for thebrand. A further £lm televisioncampaign this Winter willpromote Beechams HotRemedies. This follows lastyears repackaging of therange, which helped togenerate increased sales forall three variants, say the popularity ofblackcurrant and hot lemonwith honey, the countrysfavourite flavour is hotlemon, according to SBs tastetrials. Smithkline Beecham sayDay Nurse and Night Nursehave a 30 per cent share of thepharmacy only cold remedy. remedies range wasrelaunched last month withthe addition of several newproducts including hot lemoncold powder with vitamin C,night cold comfort and coldrelief capsules. A SUPPLEMENT TO CHEMIST & DRUGGIST 2 NOVEMBER 1991 decongestant market is staticin volume, and is wortharound £ (includingBoots, moving annual total toMarch/April 91), say the non-pharmacy-market is worth around£, growing at around 13per cent value they say. VicksSinex is a main player in thismarket. Mike Dallman, productmanager for Otrivine, says itshigher sale during Winterindicates higher usage forcolds rather than allergy. Buthe says pharmacists havefailedf to merchandise anddisplay it appropriately,bearing in min d the GSL, butpharmacy restricted, recommends dual siting:Consumers are looking toself select; it is a typically SUDAFED WEUCOW MUEFFHM*COUGHS AND (0U»


Size: 1388px × 1800px
Photo credit: © The Reading Room / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: ., bookcentury1800, bookdecade185, booksubjectpharmacy, bookyear1859